Unity Biotechnology
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,902 | $0 |
Gross Profit | -216 | -221 | -227 | |
EBITDA | -6,265 | -5,058 | -5,563 | |
EBIT | -6,481 | -5,279 | -5,790 | |
Net Income | -6,481 | -5,279 | -5,790 | -1,498 |
Net Change In Cash | 0 | 0 | 1,902 | 0 |
Free Cash Flow | -5,193 | -4,584 | -5,183 | -7,575 |
Cash | 8,898 | 7,584 | 7,430 | 19,803 |
Basic Shares | 16,849 | 16,815 | 16,785 | 16,784 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $236 | $4,784 | $0 |
Gross Profit | -19,699 | -1,944 | 1,904 | -3,449 |
EBITDA | -37,283 | -38,731 | -54,668 | -89,103 |
EBIT | -38,465 | -40,911 | -57,548 | -92,552 |
Net Income | -39,860 | -57,747 | -60,039 | -91,869 |
Net Change In Cash | 0 | 236 | 4,784 | 0 |
Cost of Revenue | -20,719 | -19,666 | ||
Free Cash Flow | -37,099 | -51,125 | -45,255 | -78,979 |
Cash | 19,803 | 12,736 | 32,905 | 17,807 |
Basic Shares | 14,773 | 9,494 | 5,581 | 5,086 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.38 |
2024-06-30 | -$0.31 |
2024-03-31 | -$0.34 |
2023-12-31 | -$0.28 |
